Cipla partners with Qilu Pharmaceutical to license, supply biosimilar Keytruda
Cipla says it has partnered with Qilu Pharmaceutical for licensing and supply of a biosimilar to Keytruda for use in the US.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.